{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&_page=0&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1682273", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1682273/answer", "answerText" : {"_value" : "<p><em>The <\/em>NHS Business Services Authority and the National Health Service promote the NHS Low Income Scheme and prescription pre-payment certificates (PPCs) to professionals and patients. It does this through social media, online resources, media releases and healthcare bulletins.<\/p><p>Our extensive arrangements to help people afford NHS prescription charges, means that almost 89% of prescription items in England are already provided free of charge. For those not exempt from charges, PPCs can be used to cap costs at approximately £2 a week for regular prescriptions.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-22T16:02:27.947Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS Low Income Scheme: Chronic Illnesses"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what steps they are taking to promote (1) the NHS Low Income Scheme to chronically ill patients, including Hidradenitis suppurativa patients, and (2) the use of pre-payment prescription certificates to chronically ill patients, including Hidradenitis suppurativa patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL1556"}
    , {"_about" : "http://data.parliament.uk/resources/1682274", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1682274/answer", "answerText" : {"_value" : "<p>While we are not considering adding this or other conditions to the list of exemptions for free prescriptions, there are extensive arrangements currently in place to ensure that prescriptions are affordable for patients with hidradentis suppurativa.<\/p><p>Around 89% of prescriptions are dispensed free of charge and extensive arrangements are already in place to help those with the greatest need. Eligibility depends on the patient\u2019s age, whether they are in qualifying full-time education, whether they are pregnant or have recently given birth, or whether they are in receipt of certain benefits or a war pension.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-22T16:01:21.867Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hidradenitis Suppurativa: Prescriptions"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what consideration they have given to including Hidradenitis suppurativa (HS) to the list of specified medical conditions qualifying for free prescriptions, given the high out-of-pocket costs for HS patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL1557"}
    , {"_about" : "http://data.parliament.uk/resources/1682275", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1682275/answer", "answerText" : {"_value" : "<p>As set out in the Government response to the <em>Occupational Health: Working Better<\/em> consultation published last year, the Government will develop a voluntary minimum framework for quality occupational health, aiming to set out the minimum level of provision that employers can adopt to support those with health conditions and disabilities in the workplace. This builds on the development of a digital information and advice service for employers, offering tailored guidance on health and disability, to equip employers to have work and health conversations and signpost to sources of expert support. A copy of the Government response to the consultation is attached.<\/p><p> <\/p><p>The Government also announced that it will identify longer-term options to build multidisciplinary workforce capability in work and health, building on existing work with the sector and exploring opportunities for businesses and providers to improve support for their employees. The Occupational Health Workforce Expansion Funding Scheme launched in July 2023 funds doctors and nurses to undertake occupational health training courses and qualifications with 99 doctors and nurses trained to date.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1682275/answer/attachment/1", "fileName" : {"_value" : "occupational-health-working-better-responses.pdf"}
          , "title" : "Occupational Health - Working Better"}
        , "dateOfAnswer" : {"_value" : "2024-01-23", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-23T15:35:13.427Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hidradenitis Suppurativa: Employment"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what steps they are taking to inform and educate employers and occupational health professionals about the specific workplace adaptations that people with Hidradenitis suppurativa may require.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL1558"}
    , {"_about" : "http://data.parliament.uk/resources/1682277", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1682277/answer", "answerText" : {"_value" : "<p>In January 2021, and in conjunction with the Social Partnership Forum, NHS England developed and published a national Violence Prevention and Reduction Standard. This supports employers in their efforts to provide a safe and secure working environment for National Health Service staff, with a focus on risk management, training and support for those impacted by incidences of violence or aggression.<\/p><p>£8.4 million has been invested into the ambulance service sector to explore the efficacy of body worn cameras in reducing violence and abuse. All ambulance trusts are now trialling cameras and an independent evaluation is underway with a final report expected towards the end of 2024.<\/p><p>In 2022, the Government legislated through the Police, Crime, Sentencing and Courts Act to double the sentence for assaults on emergency workers to a maximum of two years.<\/p><p>We do not currently have a national mechanism to assess the levels of violence and aggression in the NHS on staffing levels. NHS employing organisations have a duty of care to support the health and safety of their staff and they do collect data on incidents. This is used to inform local strategies for reducing and dealing with violence and aggression.<\/p><p>The NHS Staff Survey does ask questions relating to incidences of violence, harassment, and abuse. The 2022 NHS Staff Survey indicated that 14.7% of NHS staff have self-reported that they had experienced at least one incident of physical violence from patients, service users, relatives, or other members of the public in the last 12 months.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2024-01-22", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2024-01-22T17:25:06.77Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2024-01-15", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Health Professions: Crimes of Violence"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what steps they are taking to reduce rates of violence experienced by front line healthcare workers; and what assessment they have made of the effect of such violence on staffing levels.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL1560"}
    , {"_about" : "http://data.parliament.uk/resources/1672758", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1672758/answer", "answerText" : {"_value" : "<p>Integrated care boards (ICBs) assess the financial stability of companies subject to the current rules on procurement, including the Public Contract Regulations 2015. ICBs are responsible for their own due diligence and governance surrounding procurement, the award of contracts, and the assessment of suppliers for those purposes.<\/p><p>The Department has not made a central assessment of the overall financial stability of private companies providing services to the National Health Service.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-11-30", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-11-30T17:34:50.287Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-11-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Private Sector"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government how integrated care boards assess the initial and continuing financial stability of private companies from which NHS services are commissioned, and what assessment they have made of the overall financial stability of private companies providing NHS services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL544"}
    , {"_about" : "http://data.parliament.uk/resources/1672759", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1672759/answer", "answerText" : {"_value" : "<p>Norfolk and Waveney Integrated Care Board (ICB) and One Norwich Practices have been working constructively to identify appropriate alternative providers and develop plans to transfer services and staff. The ICB\u2019s immediate priorities are to ensure that disruption to patient care is minimised and to protect the wellbeing of staff at One Norwich Practices. Once these immediate priorities are addressed, the ICB will be in a position to undertake its own internal review of the circumstances that may have contributed to One Norwich Practices\u2019 insolvency.<\/p><p>As a commissioner, the ICB is not in receipt of the financial information of its contractors, and the ICB is not responsible for the financial viability of any organisation, nor any subsequent arrangements, financial or otherwise, within a wider group of companies or partners with whom the ICB does not directly commission services.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-11-30", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-11-30T17:23:50.593Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-11-23", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Private Sector"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government, following the decision by One Norwich Practices to stop providing services to the NHS, including a walk-in centre, because of financial problems, whether they will conduct an investigation into the board of that company and its management of services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL545"}
    , {"_about" : "http://data.parliament.uk/resources/1668656", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1668656/answer", "answerText" : {"_value" : "<p>Medicine supply problems can occur for several reasons. For example, they can be due to manufacturing difficulties, regulatory problems, problems with the supply of raw materials, sudden demand spikes or from issues which are related to the distribution of the product. The production of medicines is complex and highly regulated, and materials and processes must meet rigorous safety and quality standards. Occasionally, the National Health Service experiences temporary shortages of specific medicines.<\/p><p> <\/p><p>We know how frustrating and distressing the possibility of shortages can be and we acknowledge that there have been challenges recently with access to a limited number of medicines. We want to assure patients that the Department has well-established processes to prevent, manage and mitigate medicine shortages and works with the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, NHS England, the devolved governments and others operating in the supply chain to help ensure patients have access to the treatments they need.<\/p><p> <\/p><p>The Department routinely shares information about medicine supply issues directly with the NHS so they can put management plans in place to mitigate the risk of the shortage impacting patients and inform their patients about what it might mean for them. If any patient is concerned about their treatment, they should discuss this with their pharmacist or general practitioner.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-11-20", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-11-20T14:08:02.76Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-11-08", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Drugs"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what action they plan to take to resolve the shortages of more than 100 medicines, as reported by the British Generic Manufacturers Association.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL92"}
    , {"_about" : "http://data.parliament.uk/resources/1666274", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1666274/answer", "answerText" : {"_value" : "<p>Whilst no specific assessment has been made of Nolan and Ormondroyd\u2019s systematic review published in March 2023 or Emma Wilkinson\u2019s article published in October 2022, the Government recognises both the opportunities and risks raised by direct-to-consumer genomic tests and is committed to ensuring effective and proportionate regulation.<\/p><p>In consideration of the regulation of direct-to-consumer genetic and health testing, the Medicines and Healthcare products Regulatory Agency is working to develop a robust, world-leading regulatory regime for such medical devices that prioritises patient safety.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-10-25", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL10677"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-10-25T11:20:51.557Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-10-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Genetics: Screening"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they have made of Nolan and Ormondroyd\u2019s systematic review published on 30 March in Clinical Genetics, setting out the consequences for consumers and health services of direct-to-consumer genetic testing and how it relates to equitable healthcare; and what assessment they have made of the regulation of direct-to-consumer genetic testing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL10676"}
    , {"_about" : "http://data.parliament.uk/resources/1666275", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1666275/answer", "answerText" : {"_value" : "<p>Whilst no specific assessment has been made of Nolan and Ormondroyd\u2019s systematic review published in March 2023 or Emma Wilkinson\u2019s article published in October 2022, the Government recognises both the opportunities and risks raised by direct-to-consumer genomic tests and is committed to ensuring effective and proportionate regulation.<\/p><p>In consideration of the regulation of direct-to-consumer genetic and health testing, the Medicines and Healthcare products Regulatory Agency is working to develop a robust, world-leading regulatory regime for such medical devices that prioritises patient safety.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "dateOfAnswer" : {"_value" : "2023-10-25", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "HL10676"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-10-25T11:20:51.617Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-10-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Genetics: Screening"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what assessment they have made of Emma Wilkinson\u2019s article published in October 2022 in The BMJ on the impact of direct-to-consumer testing on the public and the NHS, and of how this relates to the regulation of direct-to-consumer health testing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL10677"}
    , {"_about" : "http://data.parliament.uk/resources/1664770", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1664770/answer", "answerText" : {"_value" : "<p>Medical practitioners are expected to state the cause of death on death certificates to the best of their knowledge and belief, including where a resistant infection was a contributory factor. Consistently citing antimicrobial resistance (AMR) as a cause of death on the Medical Certificate of Cause of Death (MCCD) could provide better data on the scale and impact of AMR and improve public awareness of the issue.<\/p><p>In November 2022, as part of the National Medical Examiner\u2019s \u201cGood Practice Series\u201d, the Royal College of Pathologists published a paper to help medical examiner offices align with the UK AMR National Action Plan, and support surveillance of antimicrobial resistance. The paper asks medical examiners to encourage and educate those writing MCCDs to accurately record the organism responsible for the infection, whether it was resistant to microbial therapy, and whether the infection was hospital- or community-associated, where this is known. A copy of the paper is attached.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Markham"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1664770/answer/attachment/1", "fileName" : {"_value" : "Good-Practice-Series-Recording-antimicrobial-resistance-on-the-Medical-Certificate-of-Cause-of-DeathFinal (1).pdf"}
          , "title" : "Good Practice Series "}
        , "dateOfAnswer" : {"_value" : "2023-10-25", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2023-10-25T11:17:39.617Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2023-10-16", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Antimicrobials: Drug Resistance"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask His Majesty's Government what progress they have made towards introducing the recording of antimicrobial resistance as a cause of death on death certificates.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4719", "label" : {"_value" : "Biography information for Baroness Bennett of Manor Castle"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Bennett of Manor Castle"}
      ], "uin" : "HL10490"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?tablingMemberPrinted.=Baroness+Bennett+of+Manor+Castle&_page=1&min-questionFirstAnswered.=2020-08-03T11%3A41%3A55.327Z&answeringDeptId=17&max-ddpModified.=2024-01-22T16%3A33%3A14.109Z", "page" : 0, "startIndex" : 1, "totalResults" : 96, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}